Additive coclastogenicity of sodium selenite and caffeine in CHO cells treated with N-methyl-N'-nitro-N-nitrosoguanidine.
The clastogenic effect of N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) in Chinese hamster ovary (CHO) cells and its modulation by Na2SeO3 and caffeine were studied by metaphase analysis of chromosome aberrations (CA) as well as by measuring the formation and repair of single-strand (ss) DNA breaks employing hydroxylapatite chromatography. Treatment of CHO cells with MNNG (1.25 or 2.5 x 10-5M) for 3 h caused CA in 11 and 19% of metaphases scored, respectively. Pretreatment of cells with Na2SeO3 (1-5 micrograms/mL) or caffeine (0.2-2.0 mg/mL) for 2 h resulted in a 2-3.5-fold increase of CA frequency. Addition of both modulators during the mutagen exposure tended to cause a slight inhibition of clastogenic activity of MNNG (1.25 x 10(-5) M) or had no effect on CA number when MNNG was used at a concentration of 2.5 x 10(-5) M). Posttreatment of CHO cells with Na2SeO3 for 20 h after MNNG was ineffective in influencing the number of metaphases with CA, whereas, at these conditions, caffeine enhanced up to 6-7-fold the clastogenic activity of MNNG. Addition of both modulators during the whole experiment, 2 h pretreatment included, resulted in a further significant increase of CA frequency up to the total pulverization of chromosomes in all metaphases scored. The coclastogenic effect of caffeine was greater in this case. The enhancement of chromosome-damaging activity of MNNG by selenite and caffeine was better expressed when this carcinogen was applied at the higher concentration used. An additive coclastogenic effect was observed in CHO cells treated simultaneously with Na2SeO3 and caffeine plus MNNG.(ABSTRACT TRUNCATED AT 250 WORDS)
Balansky
R
R
Institute of Hygiene and Preventive Medicine, University of Genoa, Italy.
Adomat
H
H
Bryson
L
L
D000818:Animals; D016466:CHO Cells; D002110:Caffeine / Q000494:pharmacology*; D002869:Chromosome Aberrations; D006224:Cricetinae; D004249:DNA Damage; D004260:DNA Repair / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D008769:Methylnitronitrosoguanidine / Q000494:pharmacology*; D009152:Mutagenicity Tests; D009153:Mutagens / Q000494:pharmacology*; D018038:Sodium Selenite / Q000494:pharmacology*
D009153:Mutagens; D008769:Methylnitronitrosoguanidine; D002110:Caffeine; D018038:Sodium Selenite